Clinical trial
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
NCT00997503 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- July 31, 2015
- Enrollment
- 4,199 (actual)
- Sites
- 82
Conditions
As the registry lists them; a condition with its own page is linked.